Arcadia Biosciences Stock Performance
| RKDA Stock | USD 2.06 0.03 1.48% |
The firm shows a Beta (market volatility) of 0.55, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Arcadia Biosciences' returns are expected to increase less than the market. However, during the bear market, the loss of holding Arcadia Biosciences is expected to be smaller as well. Arcadia Biosciences has an expected return of -0.27%. Please make sure to confirm Arcadia Biosciences skewness, day typical price, and the relationship between the maximum drawdown and daily balance of power , to decide if Arcadia Biosciences performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Arcadia Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's fundamental indicators remain somewhat strong which may send shares a bit higher in May 2024. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
Actual Historical Performance (%)
One Day Return (3.53) | Five Day Return 6.02 | Year To Date Return (30.05) | Ten Year Return (99.97) | All Time Return (99.97) |
Last Split Factor 1:40 | Dividend Date 2018-01-24 | Last Split Date 2023-03-01 |
1 | Purchase by Thomas Schaefer of 700 shares of Arcadia Biosciences | 02/05/2024 |
2 | Arcadia Biosciences Earns Sell Rating from Analysts at StockNews.com - Defense World | 03/11/2024 |
3 | Arcadia Biosciences Announces Date of Fourth Quarter 2023 Financial Results and Business Highlights Conference Call | 03/14/2024 |
4 | Acquisition by Kevin Comcowich of 21320 shares of Arcadia Biosciences at 3.69 subject to Rule 16b-3 | 03/15/2024 |
5 | Arcadia Biosciences Q4 Earnings Snapshot | 03/28/2024 |
6 | Arcadia Biosciences Q4 Earnings Beat Mark, Sales Up YY | 04/01/2024 |
7 | Arcadia Biosciences, Inc. Analysts Are Pretty Bullish On The Stock After Recent Results - Yahoo Movies UK | 04/08/2024 |
8 | Recent Research Analysts Ratings Changes for Arcadia Biosciences - Defense World | 04/18/2024 |
| Begin Period Cash Flow | 20.6 M |
Arcadia |
Arcadia Biosciences Relative Risk vs. Return Landscape
If you would invest 254.00 in Arcadia Biosciences on January 26, 2024 and sell it today you would lose (48.00) from holding Arcadia Biosciences or give up 18.9% of portfolio value over 90 days. Arcadia Biosciences is currently does not generate positive expected returns and assumes 3.738% risk (volatility on return distribution) over the 90 days horizon. In different words, 33% of stocks are less volatile than Arcadia, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Arcadia Biosciences Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Arcadia Biosciences' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Arcadia Biosciences, and traders can use it to determine the average amount a Arcadia Biosciences' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0721
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | RKDA |
Estimated Market Risk
| 3.74 actual daily | 33 67% of assets are more volatile |
Expected Return
| -0.27 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.07 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Arcadia Biosciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Arcadia Biosciences by adding Arcadia Biosciences to a well-diversified portfolio.
Arcadia Biosciences Fundamentals Growth
Arcadia Stock prices reflect investors' perceptions of the future prospects and financial health of Arcadia Biosciences, and Arcadia Biosciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Arcadia Stock performance.
| Return On Equity | -0.78 | |||
| Return On Asset | -0.34 | |||
| Profit Margin | (2.62) % | |||
| Operating Margin | (2.40) % | |||
| Current Valuation | (8.01 M) | |||
| Shares Outstanding | 1.36 M | |||
| Price To Earning | 4.84 X | |||
| Price To Book | 0.21 X | |||
| Price To Sales | 0.50 X | |||
| Revenue | 5.33 M | |||
| Gross Profit | (2.22 M) | |||
| EBITDA | (12.88 M) | |||
| Net Income | (13.16 M) | |||
| Cash And Equivalents | 21.23 M | |||
| Cash Per Share | 0.96 X | |||
| Total Debt | 1.01 M | |||
| Debt To Equity | 0.09 % | |||
| Current Ratio | 6.34 X | |||
| Book Value Per Share | 9.99 X | |||
| Cash Flow From Operations | (15.29 M) | |||
| Earnings Per Share | (10.64) X | |||
| Market Capitalization | 2.93 M | |||
| Total Asset | 19.7 M | |||
| Retained Earnings | (271.84 M) | |||
| Working Capital | 11.38 M | |||
| Current Asset | 52.02 M | |||
| Current Liabilities | 3.45 M | |||
About Arcadia Biosciences Performance
To evaluate Arcadia Biosciences Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Arcadia Biosciences generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Arcadia Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Arcadia Biosciences market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Arcadia's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 216.57 | 187.08 | |
| Return On Tangible Assets | (0.71) | (0.75) | |
| Return On Capital Employed | (0.86) | (0.90) | |
| Return On Assets | (0.71) | (0.74) | |
| Return On Equity | (1.09) | (1.03) |
Things to note about Arcadia Biosciences performance evaluation
Checking the ongoing alerts about Arcadia Biosciences for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Arcadia Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Arcadia Biosciences generated a negative expected return over the last 90 days | |
| Arcadia Biosciences has high historical volatility and very poor performance | |
| Arcadia Biosciences has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 5.33 M. Net Loss for the year was (13.16 M) with loss before overhead, payroll, taxes, and interest of (2.22 M). | |
| Arcadia Biosciences currently holds about 21.23 M in cash with (15.29 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.96. | |
| Arcadia Biosciences has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Recent Research Analysts Ratings Changes for Arcadia Biosciences - Defense World |
- Analyzing Arcadia Biosciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Arcadia Biosciences' stock is overvalued or undervalued compared to its peers.
- Examining Arcadia Biosciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Arcadia Biosciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Arcadia Biosciences' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Arcadia Biosciences' stock. These opinions can provide insight into Arcadia Biosciences' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Arcadia Biosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. For information on how to trade Arcadia Stock refer to our How to Trade Arcadia Stock guide.Note that the Arcadia Biosciences information on this page should be used as a complementary analysis to other Arcadia Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for Arcadia Stock analysis
When running Arcadia Biosciences' price analysis, check to measure Arcadia Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcadia Biosciences is operating at the current time. Most of Arcadia Biosciences' value examination focuses on studying past and present price action to predict the probability of Arcadia Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcadia Biosciences' price. Additionally, you may evaluate how the addition of Arcadia Biosciences to your portfolios can decrease your overall portfolio volatility.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Stocks Directory Find actively traded stocks across global markets | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
Is Arcadia Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arcadia Biosciences. If investors know Arcadia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arcadia Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.63) | Earnings Share (10.64) | Revenue Per Share 4.309 | Quarterly Revenue Growth 0.573 | Return On Assets (0.34) |
The market value of Arcadia Biosciences is measured differently than its book value, which is the value of Arcadia that is recorded on the company's balance sheet. Investors also form their own opinion of Arcadia Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Arcadia Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arcadia Biosciences' market value can be influenced by many factors that don't directly affect Arcadia Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arcadia Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Arcadia Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arcadia Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.